Liu J et al. |
MicroRNA-32 promotes calcification in vascular smooth muscle cells: Implications as a novel marker for coronary artery calcification. |
2017 |
PLoS ONE |
pmid:28319142
|
|
|
|
|
pmid:28320782
|
|
|
|
|
pmid:28337794
|
|
|
|
|
pmid:28363435
|
|
|
|
|
pmid:28367895
|
|
|
|
|
pmid:28373003
|
|
|
|
|
pmid:28385082
|
|
|
|
|
pmid:28386999
|
|
|
|
|
pmid:28421466
|
|
|
|
|
pmid:28429221
|
|
|
|
|
pmid:28450653
|
|
|
|
|
pmid:28473060
|
|
|
|
|
pmid:28488158
|
Spirlandeli AL et al. |
Hepatic Osteodystrophy: The Mechanism of Bone Loss in Hepatocellular Disease and the Effects of Pamidronate Treatment. |
2017 |
Clinics (Sao Paulo) |
pmid:28492723
|
|
|
|
|
pmid:28494644
|
|
|
|
|
pmid:28530511
|
Middleton K et al. |
Microfluidic co-culture platform for investigating osteocyte-osteoclast signalling during fluid shear stress mechanostimulation. |
2017 |
J Biomech |
pmid:28552413
|
|
|
|
|
pmid:28556971
|
|
|
|
|
pmid:28567553
|
|
|
|
|
pmid:28576140
|
|
|
|
|
pmid:28577080
|
|
|
|
|
pmid:28593808
|
|
|
|
|
pmid:28605877
|
Bergdolt S et al. |
Osteoblast-specific overexpression of complement receptor C5aR1 impairs fracture healing. |
2017 |
PLoS ONE |
pmid:28614388
|
|
|
|
|
pmid:28614819
|
|
|
|
|
pmid:28617323
|
|
|
|
|
pmid:28618255
|
|
|
|
|
pmid:28654984
|
|
|
|
|
pmid:28661441
|
|
|
|
|
pmid:28674790
|
|
|
|
|
pmid:28674791
|
|
|
|
|
pmid:28683789
|
|
|
|
|
pmid:28700003
|
|
|
|
|
pmid:28721974
|
|
|
|
|
pmid:28731198
|
Åšliwicka E et al. |
Serum irisin and myostatin levels after 2 weeks of high-altitude climbing. |
2017 |
PLoS ONE |
pmid:28732027
|
Chen X et al. |
Emodin suppresses cadmium-induced osteoporosis by inhibiting osteoclast formation. |
2017 |
Environ. Toxicol. Pharmacol. |
pmid:28738286
|
|
|
|
|
pmid:28739719
|
|
|
|
|
pmid:28742795
|
|
|
|
|
pmid:28758134
|
|
|
|
|
pmid:28772237
|
|
|
|
|
pmid:28774557
|
|
|
|
|
pmid:28805201
|
|
|
|
|
pmid:28814613
|
Choi EM et al. |
Actein alleviates 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated cellular dysfunction in osteoblastic MC3T3-E1 cells. |
2017 |
Environ. Toxicol. |
pmid:28836330
|
Tschiderer L et al. |
Osteoprotegerin concentration and risk of cardiovascular outcomes in nine general population studies: Literature-based meta-analysis involving 26,442 participants. |
2017 |
PLoS ONE |
pmid:28837646
|
Ozaki Y et al. |
Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis. |
2017 |
PLoS ONE |
pmid:28937990
|
|
|
|
|
pmid:28957555
|
|
|
|
|
pmid:29025654
|
|
|
|
|
pmid:29050490
|
|
|
|
|
pmid:29121799
|
|
|
|
|
pmid:29253005
|
|
|
|
|
pmid:29262817
|
|
|
|
|
pmid:29313442
|
|
|
|
|
pmid:29348072
|
|
|
|
|
pmid:29402836
|
Li N et al. |
Calycosin attenuates osteoporosis and regulates the expression of OPG/RANKL in ovariectomized rats MAPK signaling. |
2016 |
Pharmazie |
pmid:29441931
|
|
|
|
|
pmid:29502401
|
Simonet WS et al. |
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. |
1997 |
Cell |
pmid:9108485
|
Hofbauer LC and Heufelder AE |
Osteoprotegerin: a novel local player in bone metabolism. |
1997 |
Eur. J. Endocrinol. |
pmid:9368500
|
Miyamoto A et al. |
Establishment and characterization of an immortal macrophage-like cell line inducible to differentiate to osteoclasts. |
1998 |
Biochem. Biophys. Res. Commun. |
pmid:9464281
|
Yamaguchi K et al. |
Characterization of structural domains of human osteoclastogenesis inhibitory factor. |
1998 |
J. Biol. Chem. |
pmid:9478964
|
Yasuda H et al. |
Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. |
1998 |
Endocrinology |
pmid:9492069
|
Yasuda H et al. |
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. |
1998 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:9520411
|
Lacey DL et al. |
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. |
1998 |
Cell |
pmid:9568710
|
Tomoyasu A et al. |
Characterization of monomeric and homodimeric forms of osteoclastogenesis inhibitory factor. |
1998 |
Biochem. Biophys. Res. Commun. |
pmid:9571159
|
Bucay N et al. |
osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. |
1998 |
Genes Dev. |
pmid:9573043
|
Matsuzaki K et al. |
Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures. |
1998 |
Biochem. Biophys. Res. Commun. |
pmid:9600092
|
Emery JG et al. |
Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. |
1998 |
J. Biol. Chem. |
pmid:9603945
|
Tsukii K et al. |
Osteoclast differentiation factor mediates an essential signal for bone resorption induced by 1 alpha,25-dihydroxyvitamin D3, prostaglandin E2, or parathyroid hormone in the microenvironment of bone. |
1998 |
Biochem. Biophys. Res. Commun. |
pmid:9610359
|
Brändström H et al. |
Regulation of osteoprotegerin mRNA levels by prostaglandin E2 in human bone marrow stroma cells. |
1998 |
Biochem. Biophys. Res. Commun. |
pmid:9642127
|
Mizuno A et al. |
Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin. |
1998 |
Biochem. Biophys. Res. Commun. |
pmid:9647741
|
Tsuda E and Higashio K |
[Osteoclastogenesis inhibitory factor (OCIF)/OPG]. |
1998 |
Nippon Rinsho |
pmid:9648461
|
Kwon BS et al. |
TR1, a new member of the tumor necrosis factor receptor superfamily, induces fibroblast proliferation and inhibits osteoclastogenesis and bone resorption. |
1998 |
FASEB J. |
pmid:9657524
|
Morinaga T et al. |
Cloning and characterization of the gene encoding human osteoprotegerin/osteoclastogenesis-inhibitory factor. |
1998 |
Eur. J. Biochem. |
pmid:9688283
|
Brändström H et al. |
Tumor necrosis factor-alpha and -beta upregulate the levels of osteoprotegerin mRNA in human osteosarcoma MG-63 cells. |
1998 |
Biochem. Biophys. Res. Commun. |
pmid:9703945
|
Vidal ON et al. |
Osteoprotegerin mRNA is increased by interleukin-1 alpha in the human osteosarcoma cell line MG-63 and in human osteoblast-like cells. |
1998 |
Biochem. Biophys. Res. Commun. |
pmid:9703989
|
Mizuno A et al. |
Structure of the mouse osteoclastogenesis inhibitory factor (OCIF) gene and its expression in embryogenesis. |
1998 |
Gene |
pmid:9714833
|
Yamamoto M et al. |
Hypocalcemic effect of osteoclastogenesis inhibitory factor/osteoprotegerin in the thyroparathyroidectomized rat. |
1998 |
Endocrinology |
pmid:9724059
|
Hofbauer LC and Heufelder AE |
Osteoprotegerin and its cognate ligand: a new paradigm of osteoclastogenesis. |
1998 |
Eur. J. Endocrinol. |
pmid:9724069
|
Akatsu T et al. |
Osteoclastogenesis inhibitory factor suppresses osteoclast survival by interfering in the interaction of stromal cells with osteoclast. |
1998 |
Biochem. Biophys. Res. Commun. |
pmid:9753612
|
Takai H et al. |
Transforming growth factor-beta stimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow stromal cells. |
1998 |
J. Biol. Chem. |
pmid:9765225
|
Filvaroff E and Derynck R |
Bone remodelling: a signalling system for osteoclast regulation. |
1998 |
Curr. Biol. |
pmid:9768352
|
Hofbauer LC et al. |
Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines. |
1998 |
Biochem. Biophys. Res. Commun. |
pmid:9784422
|
Hakeda Y et al. |
Osteoclastogenesis inhibitory factor (OCIF) directly inhibits bone-resorbing activity of isolated mature osteoclasts. |
1998 |
Biochem. Biophys. Res. Commun. |
pmid:9790989
|
Horwood NJ et al. |
Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells. |
1998 |
Endocrinology |
pmid:9794488
|
Vidal NO et al. |
Osteoprotegerin mRNA is expressed in primary human osteoblast-like cells: down-regulation by glucocorticoids. |
1998 |
J. Endocrinol. |
pmid:9795357
|
Yun TJ et al. |
OPG/FDCR-1, a TNF receptor family member, is expressed in lymphoid cells and is up-regulated by ligating CD40. |
1998 |
J. Immunol. |
pmid:9834095
|
Murakami T et al. |
Transforming growth factor-beta1 increases mRNA levels of osteoclastogenesis inhibitory factor in osteoblastic/stromal cells and inhibits the survival of murine osteoclast-like cells. |
1998 |
Biochem. Biophys. Res. Commun. |
pmid:9837778
|
Akatsu T et al. |
Osteoclastogenesis inhibitory factor exhibits hypocalcemic effects in normal mice and in hypercalcemic nude mice carrying tumors associated with humoral hypercalcemia of malignancy. |
1998 |
Bone |
pmid:9855457
|
Schinke T et al. |
Molecular determinants of arterial calcification. |
1998 |
Ann. Med. |
pmid:9920355
|